2-Methylimidazole → 6-(2-Methyl-1H-imidazol-1-yl)-N-[(1R)-1-phenylethyl]pyrazin-2-amine

HRID 1787466

반응식

HRID 1787466 반응식
Cl[C:2]1[N:7]=[C:6]([NH:8][C@@H:9]([C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)[CH3:10])[CH:5]=[N:4][CH:3]=1.[CH3:17][C:18]1[NH:19][CH:20]=[CH:21][N:22]=1>>[CH3:17][C:18]1[N:19]([C:2]2[N:7]=[C:6]([NH:8][C@@H:9]([C:11]3[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=3)[CH3:10])[CH:5]=[N:4][CH:3]=2)[CH:20]=[CH:21][N:22]=1

참가 물질

3

실험 절차

In a procedure analogous to example 2, reaction of 6-chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine (150 mg, 0.64 mmol) and 2-methylimidazole (58 mg, 0.71 mmol) furnished the product (172 mg, 40%).

출처 및 근거

ORD 기록
ord-fbf04f7c536d4d9c8ddd59cb76533542
출처 데이터셋
uspto-grants-2009_03
특허 번호
US07511047B2

연결된 노트

불러오는 중…